abiraterone
Megjelenés
| Clinical data | |
|---|---|
| Pronunciation | a" bir a' ter one |
| Trade names | Zytiga, Yonsa, others |
| Other names | CB-7630; JNJ-212082; 17-(3-Pyridinyl)androsta-5,16-dien-3β-ol acetate, abiraterone (BAN UK), abiraterone acetate (JAN JP), abiraterone acetate (USAN US) |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a611046 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| Drug class | Antineoplastic |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | Unknown, but may be 50% at most on empty stomach |
| Protein binding | Abiraterone: ~99.8% (to albumin and α1-AGp) |
| Metabolism | Esterases, CYP3A4, SULT2A1 |
| Metabolites | Abiraterone, others |
| Elimination half-life | Abiraterone: 12–24 hours |
| Excretion | Feces: 88% Urine: 5% |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C26H33NO2 |
| Molar mass | 391.555 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 144 to 145 °C (291 to 293 °F) |
| |
| |
| (verify) | |
Főnév
abiraterone (tsz. abiraterones)
- abiraterone - Szótár.net (en-hu)
- abiraterone - Sztaki (en-hu)
- abiraterone - Merriam–Webster
- abiraterone - Cambridge
- abiraterone - WordNet
- abiraterone - Яндекс (en-ru)
- abiraterone - Google (en-hu)
- abiraterone - Wikidata
- abiraterone - Wikipédia (angol)